Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 31, 2015 4:28 AM ET

Capital Markets

Company Overview of ChrysCapital

Company Overview

ChrysCapital is a private equity and venture capital firm specializing in later stage, management buy-outs or buy-ins, co-investments, public equity, PIPEs, growth capital in private and listed companies, and special situations including carve outs, joint ventures. The firm focuses on the business services; information technology; consumer goods and services; financial services; real estate; healthcare with a focus on pharmaceuticals, medical diagnostics and devices; infrastructure, power, and manufacturing sectors. It makes investments in companies based in or focusing on India and United States. The firm invests between $10 million and $300 million in companies with revenues ranging betwee...

Suite 504

St. James Court

Port Louis,  

Mauritius

Founded in 1999

Phone:

230 211 5410

Fax:

230 208 6413

Key Executives for ChrysCapital

Group Manager
Managing Director, Partner, and Chief Financial Officer
Managing Director, Lead Partner, and Back-up Partner
Managing Director and Partner
Age: 38
Managing Director, Partner, and Managing Partner
Age: 57
Compensation as of Fiscal Year 2015.

ChrysCapital Key Developments

ChrysCapital Seeks Acquisitions

Sanjiv Kaul, Managing Director at ChrysCapital said, "ChrysCapital traditionally invests as growth capital but could also explore acquiring majority stake, especially in sectors such as pharmaceuticals and healthcare, financial services and information technology on a case-to-case basis".

ChrysCapital Reportedly Part-Exited Cyient

ChrysCapital is reported to have sold a portion of its investment in Cyient Limited (BSE:532175).

ChrysCapital Presents at AVCJ Private Equity & Venture Forum - India 2014, Dec-03-2014 10:30 AM

ChrysCapital Presents at AVCJ Private Equity & Venture Forum - India 2014, Dec-03-2014 10:30 AM. Venue: Taj Lands End, Band Stand, Bandra (West), Mumbai 400 050, Maharashtra, India. Speakers: Sanjay Kukreja, Managing Director.

Similar Private Companies By Industry

Company Name Region
Capital Markets Brokers Limited Middle East/Africa
International Financial Services Limited Middle East/Africa
IL&FS Investment Advisors LLC Middle East/Africa
AfriSam Mauritius Investment Holdings Limited Middle East/Africa
Radiant Trade and Investment Pvt Ltd Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
Private Placement
August 11, 2015
Infogain Corporation
Merger/Acquisition
May 28, 2015
Mankind Pharma Limited
Merger/Acquisition
March 17, 2015
Parksons Packaging Ltd.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ChrysCapital, please visit www.chryscapital.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.